Design and created by Guideline Central in participation with the American Dental Association.
American Dental Association
Publication Date: Mar 3, 2026
Page Last Updated: May 6, 2026
These updated recommendations explore the use of four different adjuncts in early oral cancer detection. The first of a multi-part series exploring cancer detection methods assesses cytology adjuncts. Part two through four of the series will examine vital staining, light-based adjuncts, and salivary tests, respectively, to be published throughout 2026.
Early detection of oral potentially malignant disorders (OPMD) and oral squamous cell carcinoma (OSCC) can improve patient prognosis. Biopsy remains the reference standard for diagnosing OPMDs and OSCC, but advances in diagnostic technologies and living guideline methodologies have created a need for updated guidance on early cancer detection. Developed in collaboration with the Center for Integrative Global Oral Health at the University of Pennsylvania School of Dental Medicine (Penn Dental Medicine), this first of a multi-part series exploring cancer detection methods provides recommendations on when cytology adjuncts may be appropriate.
Guideline Central and select third party use “cookies” on this website to enhance the user experience.
This technology helps us gather statistical and analytical information to optimize the relevant content for you.
The user also has the option to opt-out which may have an effect on the browsing experience.